Industry Supported Sessions

THURSDAY, OCTOBER 27, 2022

12:30-13:30   Hall Alpha 5+6

ESGO Colloquium

Supported by Eisai & MSD

The Colloquium is organised by ESGO and supported by the industry, however the industry has no influence on the content of the programme or speaker selection.

Eisai
MSD Logo_300x300 px

ADVANCES IN ENDOMETRIAL CANCER

Chair: Nicole Concin (Austria/Germany)

Speakers:

The importance of the molecular classification as predictive factor in endometrial carcinoma: Carien Creutzberg (Netherlands)

The role of IO in in first-line endometrial cancer: Toon Van Gorp (Belgium)

The role of TKI’s in second-line recurrent endometrial cancer (lenvatinib, selinexor): Jose Alejandro Pérez-Fidalgo (Spain)

 

12:30-13:30   Hall Alpha 3+4

Industry symposium 1

Supported by Novocure

 

Novocure_main@5x-100

NEW PERSPECTIVES IN PLATINUM-RESISTANT OVARIAN CANCER:

TT FIELDS AND UPCOMING THERAPIES

 

Chairs: Jalid Sehouli (Germany) and Ignace Vergote (Belgium)

Speakers: Susana Banerjee (UK), Isabelle Ray-Coquard (France), David Cibula (Czech Republic), and Martin Glas (Germany)

FRIDAY, OCTOBER 28, 2022

07:30-08:30  Hall Alpha 3+4

Industry symposium 2

Supported by Mersana

Mersana logo - CMYK - vector - JPEG (002) (002)

ANTIBODY DRUG CONJUGATES IN TREATING PLATINUM-SENSITIVE OVARIAN CANCER: OPTIONS BEYOND PARPI

 

Chair: Mansoor Raza Mirza (Denmark)

Speakers: Susana Banerjee (UK), Philipp Harter (Germany), Antonio Gonzalez Martin (Spain)

 

 

12:30-13:30   Hall Aplha 5+6

Industry symposium 3

Supported by AstraZeneca

AstraZeneca_RGB_H_COL

LONG-TERM SURVIVAL FOR PATIENTS WITH NEWLY-DIAGNOSED ADVANCED OVARIAN CANCER:

WHAT IS THE GOAL, AND HOW CAN IT BE REACHED?

 

Chair: Ana Oaknin (Spain)

Speakers: Kathleen Moore (USA), Jonathan Ledermann (UK)

                               

12:30-13:30   Hall Alpha 3+4

Industry symposium 4

Supported by MSD

MSD Logo_300x300 px

EMERGING IO LANDSCAPE IN GYNECOLOGICAL CANCERS: ROLE OF BIOMARKER TESTING AND MDT APPROACHES

 

Chair: Domenica Lorusso (Italy)

Speaker: Hans Ulrich Schildhaus (Germany)

                               

14:40-15:40   Hall Alpha 3+4

Industry symposium 5

Supported by GSK

The_Signal

NEW ERA OF IMMUNE CHECKPOINT INHIBITORS IN ENDOMETRIAL CANCER

Chair: Jalid Sehouli (Germany)

Speakers: Mansoor Mirza (Denmark), Lucy Gilbert (Canada), Christian Marth (Austria)

 

SATURDAY, OCTOBER 29, 2022

 

11:00-12:00   Hall Alpha 8

Industry symposium 6

Supported by GSK  

The_Signal

CONVERSATIONS AND CONTROVERSIES IN FIRST-LINE MAINTENANCE THERAPY FOR ADVANCED OVARIAN CANCER

 

Chair: Philipp Harter (Germany)

Speakers: Antonio González Martín (Spain), Toon Van Gorp (Netherlands)

 

11:00-12:00   Hall Alpha 5+6

Industry symposium 7

Supported by Seagen

Seagen Logo_RGB

PARADIGM SHIFT IN RECURRENT/METASTATIC CERVICAL CANCER? WHAT TO EXPECT AND WHAT TO LOOK FOR?

Chair: Ignace Vergote (Belgium)

Speakers: Isabelle Ray-Coquard (France), David Cibula (Czech Republic), Domenica Lorusso (Italy), Ana Oaknin (Spain), Linn Wölber (Germany)

 

11:00-12:00   Hall Alpha 3+4

Industry symposium 8

Supported by Intuitive  

INTUITIVE logo blue on white 553x305px

INTEGRATION OF ROBOTIC-ASSISTED SURGERY IN YOUR GYO PROGRAM

 

Chair: Ane Gerda Eriksson (Norway)

Speakers: Jan Persson (Sweden), Philippe Van Trappen (Netherlands), Ingolf Juhasz-Böss (Germany)

 

15:10-15:25   Cinema viewing in Exhibition Hall

Product theatre

Supported by Illumina

A POWERFUL COMBINATION FOR HRD ANALYSIS

Speaker: Bert de Boer (Netherlands)

 

You may also like

ESGO_2015_24102015_0296_WEB

Reasons to Attend

 

 

Find out More

ESGO 2019 webcasts

ESGO 2023

Scientific Programme Highlights

 

Explore it Now!

speakers1

Photo Gallery

Great moments from ESGO 2022!

 

View it Now!

register

Registration

Regular rates end on Sept 10!

 

Register Now!